Heart failure and atrial fibrillation are 2 common cardiovascular disorders that frequently
complicate one another and exert a significant detrimental effect on cardiovascular health …

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with
increased morbidity and mortality. There is growing evidence that numerous cardiovascular …

Background Mortality and morbidity are higher among patients with atrial fibrillation and
heart failure than among those with heart failure alone. Catheter ablation for atrial fibrillation …

Background: Identification and elimination of nonpulmonary vein targets may improve
clinical outcomes in patients with persistent atrial fibrillation (AF). We report on the use of a …

In the context of the COVID-19 pandemic, many barriers to telemedicine disappeared.
Virtual visits and telemonitoring strategies became routine. Evidence is accumulating …

The fourth edition of Pharmacotherapy Principles & Practice is designed to provide student
learners and health care practitioners with essential knowledge of the pathophysiology and …

Cardiovascular (CV) toxicities of the Bruton tyrosine kinase (BTK) inhibitor ibrutinib may limit
use of this effective therapy in patients with chronic lymphocytic leukemia (CLL) …

Atrial fibrillation (AF) and heart failure (HF) are highly prevalent and are associated with high
health care costs and significant morbidity and mortality. In the year 2010, AF was estimated …

Background The results of studies comparing the outcomes of catheter ablation (CA) to
those of medical therapy (MT) for atrial fibrillation (AF) in heart failure (HF) patients are …

The renin-angiotensin-aldosterone system (RAAS) plays a major role in cardiovascular
health and disease. Short-term RAAS activation controls water and salt retention and causes …